Brogan, P. A. Et Al. 2021. Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open-Label, Randomized, Bayesian Noninferiority Trial. ARTHRITIS & RHEUMATOLOGY , vol.73, no.9 , 1673-1682.

Brogan, P. A., Arch, B., Hickey, H., Anton, J., Iglesias, E., Baildam, E., ... Mahmood, K.(2021). Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open-Label, Randomized, Bayesian Noninferiority Trial. ARTHRITIS & RHEUMATOLOGY , vol.73, no.9, 1673-1682.

Brogan, Paul Et Al. "Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open-Label, Randomized, Bayesian Noninferiority Trial," ARTHRITIS & RHEUMATOLOGY , vol.73, no.9, 1673-1682, 2021

Brogan, Paul A. Et Al. "Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open-Label, Randomized, Bayesian Noninferiority Trial." ARTHRITIS & RHEUMATOLOGY , vol.73, no.9, pp.1673-1682, 2021

Brogan, P. A. Et Al. (2021) . "Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open-Label, Randomized, Bayesian Noninferiority Trial." ARTHRITIS & RHEUMATOLOGY , vol.73, no.9, pp.1673-1682.

@article{article, author={Paul A. Brogan Et Al. }, title={Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open-Label, Randomized, Bayesian Noninferiority Trial}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2021, pages={1673-1682} }